Copd exacerbation steroid duration

Effects of treatment with Symbicort 160/, Symbicort 80/, formoterol mcg, or placebo on development of cataracts or glaucoma were evaluated in a subset of 461 patients with COPD in the 12-month lung function study. Ophthalmic examinations were conducted at baseline, 24 weeks, and 52 weeks. There were 26 subjects (6%) with an increase in posterior subcapsular score from baseline to maximum value (>) during the randomized treatment period. Changes in posterior subcapsular scores of > from baseline to treatment maximum occurred in 11 patients (%) in the Symbicort 160/ group, 4 patients (%) in the Symbicort 80/ group, 5 patients (%) in the formoterol group, and 6 patients (%) in the placebo group.

Copd exacerbation steroid duration

copd exacerbation steroid duration

Media:

copd exacerbation steroid durationcopd exacerbation steroid durationcopd exacerbation steroid durationcopd exacerbation steroid durationcopd exacerbation steroid duration

http://buy-steroids.org